SY-005

Recombinant Human Annexin A5 · Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SY-005, covering 2022-03-14 to 2022-03-14. Get the full timeline:

Most recent: Clinical Trial Update: SY-005 （Recombinant Human Annexin A5）in Patients With Sepsis [Phase 2]